Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
Acute treatment of migraine with a combination tablet containing sumatriptan and naproxen has better efficacy than monotherapy with either drug alone, without increased adverse events Brandes et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback